Unilever declined the initial offer, but it is likely Kraft Heinz will continue to pursue the transaction.
The number of stores to be divested to Fred’s Pharmacy was reportedly a big sticking point, but has now been resolved.
Greenlight Capital’s David Einhorn reportedly initiates position with 1.5 million Fred’s Pharmacy shares and ups Rite Aid stake to nearly 20.5 million shares in the fourth quarter.
Roche, Novartis, Pfizer and Gilead were all named as potential suitors.
A new report from Accenture has found that millions of loyalty points are sitting dormant, and the majority of U.S. consumers (78%) are retracting their loyalty at profit-crushing rates.
Aetna will pay Humana $1 billion as a result of the termination of the merger agreement. Additionally, Aetna has terminated its previously announced agreement to sell certain Medicare Advantage assets to Molina Healthcare.
Ahold Delhaize unveils plan to strengthen entire U.S. grocery division.
Sales across the North American OTC Healthcare segment were up 7.4%.
Generics have made a huge difference to the U.S. healthcare system’s bottom line in the past decade, a savings that takes 13 figures to tabulate.
The emergence of new products across the cough-cold and allergy categories is transforming the OTC aisle.